Cognitive performance of GBA mutation carriers with early-onset PD
Neurology®, Exclusive Author Commentary

Alcalay RN et al. – Glucocerebrosidase (GBA) mutation status may be an independent risk factor for cognitive impairment in patients with Parkinson disease (PD).

Parkinson's disease (PD) is very heterogeneous. Some people affected by the disease develop cognitive problems while others either do not develop cognitive problems or develop these late in the disease course. There are known risk factors for cognitive impairment in PD including older age and longer disease duration. Here, we show that GBA mutations may be an independent risk factor for cognitive problems.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Family Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Family Medicine Articles

Indexed Journals in Family Medicine: American Family Physician, Archives of Family Med, Annals of Family Medmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More